As we approach 50 years of biotechnology innovation, a generation of female leaders are reshaping the industry at some of the most influential companies in biopharma, including as CEOs of Vertex and Alnylam. Women are spearheading some of the most transformative advances in therapeutics - from RNA and cell therapies to next-gen oncology and AI-led discovery. Yet, according to statistics, women still navigate persistent gender gaps in funding, board and C-suite seats, and executive visibility. This panel convenes leading women innovators - C-Suite and senior executives across pharma and biotech - to reflect on the evolving leadership landscape. Speakers will share personal lessons from their careers and pipeline triumphs, spotlight how they are shaping scientific strategies, and reveal the leadership approaches they deploy to shift culture, power access, and opportunity for those who follow.